Plexus Corp. (NASDAQ:PLXS) Given Consensus Rating of “Buy” by Brokerages

Shares of Plexus Corp. (NASDAQ:PLXSGet Free Report) have been assigned a consensus recommendation of “Buy” from the seven research firms that are covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $273.00.

PLXS has been the topic of a number of research reports. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Needham & Company LLC reaffirmed a “buy” rating and issued a $310.00 target price on shares of Plexus in a research report on Friday, August 14th. Stifel Nicolaus lifted their price target on shares of Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Weiss Ratings cut shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, August 11th. Finally, Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective for the company in a research note on Friday, July 31st.

Read Our Latest Research Report on PLXS

Plexus Stock Up 1.6%

PLXS stock opened at $245.98 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72. The stock has a market capitalization of $6.58 billion, a P/E ratio of 36.28 and a beta of 0.89. The business has a 50-day moving average of $258.47 and a 200-day moving average of $245.28. Plexus has a fifty-two week low of $132.03 and a fifty-two week high of $307.06.

Plexus (NASDAQ:PLXSGet Free Report) last announced its earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.13 by $0.19. The business had revenue of $1.30 billion for the quarter, compared to analyst estimates of $1.23 billion. Plexus had a return on equity of 12.46% and a net margin of 4.03%.Plexus’s revenue for the quarter was up 28.2% compared to the same quarter last year. During the same quarter last year, the firm earned $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. On average, sell-side analysts anticipate that Plexus will post 7.11 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $250.98, for a total transaction of $376,470.00. Following the transaction, the chief executive officer owned 65,888 shares of the company’s stock, valued at $16,536,570.24. The trade was a 2.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Karen Rapp sold 500 shares of the business’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $240.87, for a total value of $120,435.00. Following the transaction, the director directly owned 7,535 shares in the company, valued at $1,814,955.45. This trade represents a 6.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 7,500 shares of company stock worth $2,039,375. Corporate insiders own 1.78% of the company’s stock.

Hedge Funds Weigh In On Plexus

Several hedge funds and other institutional investors have recently made changes to their positions in the company. AQR Capital Management LLC raised its position in Plexus by 103.1% during the first quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock worth $1,074,000 after acquiring an additional 4,255 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Plexus by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock valued at $2,046,000 after acquiring an additional 705 shares during the last quarter. United Services Automobile Association bought a new position in shares of Plexus in the 1st quarter valued at about $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Plexus by 12.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock valued at $10,197,000 after acquiring an additional 9,078 shares during the period. Finally, Cetera Investment Advisers acquired a new position in shares of Plexus during the 2nd quarter worth about $309,000. 94.45% of the stock is owned by institutional investors.

Plexus Company Profile

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Further Reading

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.